Application of dezocine in patient-controlled intravenous analgesia after laryngectomy:a prospective randomized controlled study / 复旦学报(医学版)
Fudan University Journal of Medical Sciences
; (6): 238-242, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1019607
Biblioteca responsável:
WPRO
ABSTRACT
Objective To investigate different doses of the analgesic effects of dezocine comparing with sufentanil after laryngectomy.Methods A total of 129 patients who underwent elective partial laryngectomy from Feb 2022 to Jan 2023 were randomly assigned to dezocine 0.5 mg/kg group(group D1),dezocine 0.6 mg/kg group(group D2)and sufentanil 2 μg/kg group(group S).Twenty-four hours amount of drugs,the visual analogue scale(visual analogue scale,VAS)and 48 h total pressing times of PCA(patient-controlled intravenous analgesia,PCIA)were compared among the three groups at 6,12,24 and 48 h after operation,and the postoperative adverse reactions(nausea,vomiting,dizziness,urinary retention and respiratory depression)were recorded.Results There was no significant difference in 24 h amount of drugs among the three groups.The VAS score of group D1 was higher than that of group S at 6 h postoperatively(P<0.05),but did not differ significantly among the three groups at 12,24 and 48 h.There was no significant differences in the number of compressions and postoperative adverse reactions among the three groups.Conclusion Compared with sufentanil,0.6 mg/kg dezocine can provide the same degree of analgesic effect.However,no advantage was found to reduce adverse reactions.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Fudan University Journal of Medical Sciences
Ano de publicação:
2024
Tipo de documento:
Article